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ABSTRACT
Background: Visceral leishmaniasis is a complex vector-borne disease caused by the protozoan Leishmania infantum. In 
urban centers of South America, where this zoonotic cycle occurs, dogs seem to be the main reservoirs and infection sources. 
Animals with canine visceral leishmaniasis (CVL) may have a wide clinical spectrum, and dogs are usually classified as 
asymptomatic, oligosymptomatic, and symptomatic. Several organs are affected in canine CVL, and renal involvement is 
often a determining factor in dog prognosis. Nevertheless, serum markers are slow to indicate loss of renal function. The 
aim of this study was to evaluate kidney impairment in dogs diagnosed with CVL.
Materials, Methods & Results: Blood and urine samples were collected from 45 dogs from Barra Mansa-RJ, and used 
for urinalysis, urine protein/creatinine (UPC) ratio, and serum concentrations of urea and creatinine. The animals were 
classified as symptomatic (42.2%), oligosymptomatic (37.8%), and asymptomatic (20.0%). Some alterations were found 
in the urine samples; pale-yellow color in 17.8%, low specific gravity in 6.7%, turbidity in 51.1%, proteinuria in 80%, 
occult blood in 46.7%, bilirubin in 8.89%, and glucose in 6.7% of the samples. According to the UPC ratio, 60% of dogs 
were proteinuric, and UPC > 2.0 was high in symptomatic dogs. Azotemia was observed only in three dogs with CVL.
Discussion: The majority of dogs presented one or more symptoms of CVL, as expected in an endemic area from Brazil. 
Pale-yellow urine was observed in some samples, and this change, when accompanied by the decreased urine specific grav-
ity in dogs with CVL, suggests some degree of kidney disease. The presence of epithelial and red blood cells, leukocytes, 
bacteria, suspended mucus, and phosphate crystals that precipitate in alkaline urines could be associated, to some degree, 
with the urine turbidity found in the present study. The alkaline urine identified in some dogs could be related to the ani-
mals’ diet, but renal tubular acidosis (RTA) is another possible cause when referring to animals with CVL. The abnormal 
presence of bilirubin and glycosuria can be justified by liver damage and glomerular and tubular damage, respectively. 
Occult blood was found in the urine of almost half of the tested dogs, which occurred because of the presence of red 
blood cells in the urine sediment and hematuria in some animals, could be caused by tubular and glomerular lesions. The 
presence of granular and hyaline casts found in the samples reinforce the possibility of tubular injury. We found different 
levels of proteinuria; it was an important result, possibly caused by immune complex deposition in addition to tubular 
disease. Most tested dogs, including animals without clinical manifestation, were classified as proteinuric or borderline 
proteinuric, showing that the renal disease could be the only clinical manifestation of CVL and that it could progress from 
slight proteinuria to end-stage renal disease, resulting in chronic renal failure, which is the main cause of death. The UPC 
ratio > 2.0 was significantly the more frequent finding in this study, mainly in symptomatic dogs. This result indicates a 
glomerular disease in these animals, reinforcing that the progression of renal disease follows the clinical progression of 
CVL. A few serum samples showed increased urea and creatinine levels, proving that azotemia is an uncommon finding 
in CVL-infected dogs. In conclusion, urinalysis helped in the early identification of renal injury in CVL-infected dogs, 
highlighting elements that reinforce the presence of tubular or glomerular lesions, or both, even in non-azotemic dogs. 
The high frequency of symptomatic dogs with UPC ratio > 2.0 suggests a relationship between the progression of renal 
disease and the clinical progression of CVL.
Keywords: Leishmania infantum, kidney disease, urinalysis, urine protein/creatinine ratio, serum biochemistry.
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INTRODUCTION
Visceral leishmaniasis is a zoonosis caused by 
the protozoan Leishmania infantum through the bite of 
phlebotomine sand flies such as Lutzomyia longipalpis 
[28,30]. In South America, the disease has expanded 
from rural to urban centers where the zoonotic cycle 
occurs, and dogs seem to be the main reservoirs and 
infection sources [17,22]. These animals with canine 
visceral leishmaniasis (CVL) may have a wide clinical 
spectrum and are usually classified as asymptomatic 
(without clinical signs), oligosymptomatic (with up 
to three clinical signs), and symptomatic (with four 
or more clinical signs). CVL lesions may involve any 
body fluid, tissue or organ, including the kidneys, and 
renal involvement usually occurs because of immune 
complex deposition [6,13,17,22,30]. Clinical symp-
toms and laboratory evidence depend on the degree 
of organ injury and may appear only when there is 
extensive tissue damage [6,11,13,18]. Therefore, pro-
teinuria initially may not be accompanied by azotemia 
in infected dogs [7]. In this context, other tools that 
help in the early diagnosis of urinary system alterations 
can be used [29]. Urinalysis is a simple, inexpensive 
three-step routine test that may assist in the identifica-
tion of systemic and other diseases that compromise 
the urinary tract [29,32]. The urine protein/creatinine 
(UPC) ratio is another useful tool in assessing kidney 
disease in dogs [5,7,11,14].
Given the importance of renal disorders in 
the clinical condition of dogs with CVL and the need 
for early diagnosis of these disorders, the aim of this 
study was to identify the occurrence of urinalysis and 




A prospective study was performed on CVL-in-
fected dogs from Barra Mansa (22°32′39″ S, 44°10′17″ 
W), a Brazilian municipality in the south of the state of 
Rio de Janeiro (RJ), within the Vale do Paraíba region. 
CVL diagnosis was based on positive results from the 
dual-path platform immunochromatographic rapid test 
(DPP®)1 and the enzyme-linked immunosorbent assay 
(ELISA) for CVL (EIE-LVC®)1. The EIE-LVC test 
was performed at the Noel Nutels Central Laboratory 
(LACEN) from Rio de Janeiro, Brazil. 
The dogs in this study were referred to the 
Laboratório de Pesquisa Clínica em Dermatozoono-
ses de Animais Domésticos (LAPCLIN-DERMZOO/
Fundação Oswaldo Cruz), where they were chemi-
cally restrained using a mixture of 10 mg/kg of ket-
amine  (Cetamin®)2 and 0.2 mg/kg of acepromazine 
(Apromazin 1%®)2 for physical examination and 
collection of blood and urine (cystocentesis) samples. 
Classification, according to the presence of typical 
CVL clinical signs, was performed as previously 
suggested [17]. The collected blood was stored in 
anticoagulant-free tubes for serum extraction.
Laboratory tests
Renal function tests (determination of serum 
concentrations of urea and creatinine) were conducted 
in an automated analyzer (Labmax 240 Premium®)3, 
using commercial kits (Labtest®)4 according to the 
manufacturer’s instructions.
To perform urinalyses, the minimum volume 
of urine obtained by cystocentesis in each dog was 5.0 
mL. Physical examination of the urine was based on a 
qualitative evaluation of the color, odor, and transpar-
ency (clear or cloudy) of the samples. Urine specific 
gravity was determined by refractometry (ATAGO SZJ-
D Refractometer®)3, and urine chemical analysis was 
performed using a dipstick test (Uriquest Plus®)4. For 
the microscopic sediment examination, a fresh urine 
sample was centrifuged in suitable tube; the superna-
tant was then decanted, and the pellet was resuspended, 
transferred to a coverslipped glass slide, and observed 
under a microscope at 400× magnification.
Moreover, UPC was calculated in all dogs. 
Urinary protein was determined by a colorimetric 
method with a pyrogallol-molybdate red complex, and 
urinary creatinine was measured by the Jaffé reaction 
using picric acid.
Statistical analysis
Qualitative variables were initially evaluated 
descriptively and later, in groups according to their 
CVL clinical status using the G-test. Quantitative 
variables were presented by their means and standard 
deviation, first in all dogs and, later, in groups accord-
ing to their CVL clinical status. Kruskal-Wallis and 
Mann-Whitney tests with independent samples and 
95% confidence interval were used to compare the 
clinical groups.
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On the basis of UPC ratio and according to the 
International Renal Interest Society (IRIS), dogs were 
considered as non-proteinuric (UPC < 0.2), borderline 
proteinuric (UPC 0.2 - 0.5), and proteinuric (UPC > 
0.5). Subsequently, proteinuric dogs were stratified by 




For this study, blood and urine were obtained 
from 45 dogs in the LAPCLIN-DERMZOO. The ani-
mals were unvaccinated against CVL and presented 
positive serological reaction in both tests that were 
applied (DPP® and ELISA). According to the physical 
examination, we observed 42.2% of symptomatic dogs 
(19/45), 37.8% of oligosymptomatic dogs (17/45), and 
20.0% of asymptomatic dogs (9/45).
Urinalysis, UPC and serum biochemistry 
The frequencies of urinalysis results obtained 
for all animals with CVL, as well as for each clinical 
group, are described in Table 1.
Examined urine samples showed predomi-
nantly a normal color (82.2%; 37/45). The abnor-
malities observed were found in 17.8% (8/45) of the 
samples. Among the samples from symptomatic dogs, 
the altered colors were pale yellow (10.5%; 2/19); 
dark yellow (5.3%; 1/19); and amber (5.3%; 1/19). 
Pale-yellow urine was found in 17.6% (3/17) of the 
oligosymptomatic dogs’ samples, and amber urine was 
found in 11.1% (1/9) of samples from asymptomatic 
dogs. There was no significant difference in the fre-
quency of normal or altered color of the urine from 
the evaluated clinical groups. In all animals, the odor 
was sui generis. Regarding urine transparency, 51.1% 
(23/45) of the samples were slightly or completely 
cloudy, while 48.9% (22/45) were totally clear. Among 
the urine samples from symptomatic animals, 47.4% 
(9/19) were cloudy or slightly cloudy (Table 1). The 
altered aspect of the urine represented 52.9% (9/17) of 
the oligosymptomatic dogs’ samples and 55.6% (5/9) 
of the asymptomatic ones. However, there was no sig-
nificant difference regarding urine turbidity between 
the evaluated clinical groups.
We found 93.3% (42/45) of dog samples 
with normal urine specific gravity and 6.7% (3/45) 
of CVL-infected dogs’ samples with urine specific 
gravity below 1,015 (from two symptomatic and one 
oligosymptomatic dog), with no statistical difference 
between the clinical groups. In most animals (60.0%; 
27/45), urine pH results were within the expected 
range; however, 26.7% (12/45) and 13.3% (6/45) 
of the animals presented alkaline and slightly acid 
urine, respectively regarding the clinical groups, 
alkaline pH was identified in 26.3% (5/19), 23.5% 
(4/17), and 33.3% (3/9) urine of symptomatic dogs, 
oligosymptomatic, and asymptomatic dogs, respec-
tively (Table 1). There was no significant difference 
between urinary pH and clinical status of the animals 
with CVL.
The presence of proteins was a remarkable 
finding in the urine chemical examination. In 80.0% 
(36/45) of dogs with CVL, proteinuria of 1+ or 
more classification was observed, especially among 
symptomatic animals (89.5%; 17/19), followed by 
asymptomatic (77.8%; 7/9) and oligosymptomatic 
dogs (70.6%; 12/17). It was also observed that 15.6% 
(7/45) of the dogs presented protein traces in their 
urine, and only in 4.4% (2/45) of the cases, the sample 
was negative for the presence of proteins (Table 1). 
There was no significant difference in the clinical 
groups evaluated.
Results greater than 1+ of bilirubin in the urine 
were identified in 15.8% (3/19) of symptomatic dogs 
and in 11.1% (1/9) of the asymptomatic dogs. The oc-
currence of occult blood and glucose was identified, 
respectively, in 46.7% (21/45) and 6.7% (3/45) of the 
samples from dogs with CVL (Table 1). There was no 
significant difference according to the animals’ clinical 
status and these variables.
Leukocytes and red blood cells were detected 
in 77.8% (35/45) and 40.0% (18/45) of the urinary 
sediment samples, respectively. The presence of leu-
kocytes and red blood cells was higher than normal 
in 8.9% (4/45) and 17.8% (8/45) of cases, respec-
tively, with no significant difference between clinical 
groups. Regarding the cellularity, 48.9% (22/45) of 
the samples presented epithelial cells of the lower 
urinary tract, which was classified as moderate or 
intense in 15.6% (7/45) of the dogs’ samples. In ad-
dition, 4.4% (2/45) and 6.7% (3/45) of the evaluated 
animals presented, respectively, renal pelvis cells and 
renal cells in the urinary sediment (Table 1). These 
animals were in the symptomatic and oligosymptom-
atic groups, although no significant difference was 
observed between them.
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Table 1. Frequencies of physical, chemical and urinary sediment results of dogs with serological diagnosis of canine visceral leishmaniasis from Barra 
Mansa, RJ - Brazil according to clinical groups.
Variable Dogs Symptomatic Oligosymptomatic Asymptomatic Reference*
Color n (%)
Normal 37 (82.2) 15 (78.9) 14 (82.4) 8 (88.9)
Yellow
Altered 8 (17.8) 4 (21.1) 3 (17.6) 1 (11.1)
Transparency n (%)
Clear 22 (48.9) 10 (52.6) 8 (47.1) 4 (44.4)
Clear
Cloudy 23 (51.1) 9 (47.4) 9 (52.9) 5 (55.6)
Urine specific gravity n (%)
Normal 42 (93.3) 17 (89.5) 16 (94.1) 9 (100)
1,015 to 1,045
< 1,015 3 (6.7) 2 (10.5) 1 (5.9) 0
pH n (%)
< 5.5 6 (13.3) 3 (15.8) 1 (5.9) 2 (22.2)
5.5 – 7.55.5 - 7.5 27 (60.0) 11 (57.9) 12 (70.6) 4 (44.4)
> 7.5 12 (26.7) 5 (26.3) 4 (23.5) 3 (33.3)
Protein n (%)
Negative 2 (4.4) 1 (5.3) 1 (5.9) 0
Negative to traceTrace 7 (15.6) 1 (5.3) 4 (23.5) 2 (22.2)
≥ 1+ 36 (80.0) 17 (89.5) 12 (70.6) 7 (77.8)
Bilirubin n (%)
Negative 28 (62.2) 9 (47.4) 12 (70.6) 7 (77.8)
Negative to weak positive1+ 13 (28.9) 7 (36.8) 5 (29.4) 1 (11.1)
> 1+ 4 (8.9) 3 (15.8) 0 1 (11.1)
Occult blood n (%)
Negative 24 (53.3) 11 (57.9) 9 (52.9) 4 (44.4)
Negative to trace
≥ 1+ 21 (46.7) 8 (42.1) 8 (47.1) 5 (55.6)
Glucose n (%)
Negative 42 (93.3) 18 (94.7) 16 (94.1) 8 (88.9)
Negative
≥ 1+ 3 (6.7) 1 (5.3) 1 (5.9) 1 (11.1)
Leukocytes n (%)
Absent 10 (22.2) 4 (21.1) 3 (17.6) 3 (33.3)
< 3/hpf1 - 3/hpf 31 (68.9) 14 (73.7) 12 (70.6) 5 (55.6)
> 3/hpf 4 (8.9) 1 (5.3) 2 (11.8) 1 (11.1)
Red Blood Cells n (%)
Absente 27 (60.0) 13 (68.4) 10 (58.8) 4 (44.4)
0 - 3/hpf1 - 3/hpf 10 (22.2) 4 (21.1) 3 (17.7) 3 (33.3)
> 3/hpf 8 (17.8) 2 (10.5) 4 (23.5) 2 (22.2)
Epithelial cells n (%)
Absent 23 (51.1) 9 (47.4) 9 (52.9) 5 (55.6)
Few
Discreet 1+ 15 (33.3) 8 (42.1) 5 (29.4) 2 (22.2)
Mild 2+ 6 (13.3) 2 (10.5) 2 (11.8) 2 (22.2)
Intense 3+ 1 (2.2) 0 1 (5.9) 0
Pelvis cells n (%)
Absent 43 (95.6) 18 (94.7) 16 (94.1) 9 (100)
0
Present 2 (4.4) 1 (5.3) 1 (5.9) 0
Renal cells n (%)
Absent 42 (93.3) 18 (94.7) 15 (88.2) 9 (100)
0
Present 3 (6.7) 1 (5.3) 2 (11.8) 0
Granular casts n (%)
Absent 22 (48.9) 7 (36.8) 11 (64.7) 4 (44.4)
Absent1+ 22 (48.9) 12 (63.2) 6 (35.3) 4 (44.4)
2+ 1 (2.2) 0 0 1 (11.1)
Hyaline casts n (%)
Absent 38 (84.4) 15 (78.9) 15 (88.2) 8 (88.9)
Absent
Present 7 (15.6) 4 (21.1) 2 (11.8) 1 (11.1)
Crystals (amorphous phosphates) n (%)
Absent 27 (60.0) 12 (63.2) 9 (52.9) 6 (66.7)
Absent
Present 18 (40.0) 7 (36.8) 8 (47.1) 3 (33.3)
Crystals (struvite) n (%)
Absent 39 (86.7) 17 (89.5) 14 (82.3) 8 (88.9)
Absent
Present 6 (13.3) 2 (10.5) 3 (17.7) 1 (11.1)
Crystals (calcium oxalate) n (%)
Absent 43 (95.6) 18 (94.7) 17 (100) 8 (88.9)
Absent
Present 2 (4.4) 1 (5.3) 0 1 (11.1)
Bacteria n (%)
Absent 27 (60.0) 9 (47.4) 11 (64.7) 7 (77.8)
Absent
Present 18 (40.0) 10 (52.6) 6 (35.3) 2 (22.2)
Total 45 (100) 19 (100) 17 (100) 9 (100) -
*Chew et al. [5]; Stockham & Scott [32]. hpf: high-power field.
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Granular casts were detected in 51.1% (23/45) of 
the studied animals’ urine, with the discrete quantity being 
predominant (63.2% of symptomatic animals, 35.3% of 
oligosymptomatic animals, and 44.4% of asymptomatic 
animals). Hyaline casts in the samples were observed 
in 15.6% (7/45) of dogs with CVL, always in discrete 
quantities (21.1% of symptomatic dogs, 11.8% of oligo-
symptomatic dogs, and 11.1% of asymptomatic dogs).
The crystals found in the urinary sediments 
were predominantly characteristic of alkaline pH, total-
ing 40.0% (18/45) of amorphous phosphate and 13.3% 
(6/45) of struvite crystals. We also found 4.4% (2/45) 
of samples containing calcium oxalate. The presence of 
bacteria, in different degrees, was seen in 40.0% (18/45) 
of samples from dogs with CVL. This finding was more 
frequent among symptomatic animals (52.6%), followed 
by oligosymptomatic animals (35.3%), and asymptom-
atic animals (22.2%). There was no significant difference 
between the presence of casts, crystals, or bacteria, and 
the clinical status of the animal.
The mean values obtained for urinary protein 
and creatinine are shown in Table 2. No   significant dif-
ference was observed between the urinary proteins and 
creatinine in the clinical groups (Table 2). According to 
UPC ratio values (Table 3), dogs in the present study were 
considered predominantly proteinuric (60.0%; 27/45). Of 
the evaluated animals, 22.2% (10/45) were considered 
borderline proteinuric, and 17.8% (8/45) were classified 
as non-proteinuric. Stratification of proteinuric dogs (n 
= 27) revealed 51.9% of UPC ratio > 2.0; 29.6% of UPC 
ratio from 1.0 to 2.0; and 18.5% of UPC ratio from 0.5 to 
1.0. The presence of dogs with UPC ratio above 2.0 was 
significantly higher (P = 0.0020) than the others, being 
more marked in symptomatic dogs.
Although the increase in serum urea concentra-
tion has been found in 51.1% of the evaluated dogs, the 
simultaneous increase in serum urea and serum creati-
nine levels was observed only in 6.7% (3/45) of dogs 
with CVL, and this azotemia was observed in one animal 
from each clinical group, without significant difference.
Table 2. Mean ± standard deviation for urinary values of protein and creatinine, and of urine protein/creatinine ratio for dogs with serological 
diagnosis of canine visceral leishmaniasis from Barra Mansa, RJ - Brazil according to clinical groups.
Variable
Dogs Symptomatic Oligosymptomatic Asymptomatic
Statistical Analysis
Mean ± SD
UPr (mg/dL) 185.6 ± 238.3 142.2 ± 141.6 241.9 ± 339.5 170.6 ± 158.9 Not significant
UCr (mg/dL) 120.9 ± 80.2 119.9 ± 104.0 112.0 ± 60.9 139.8 ± 55.1 Not significant
UPC ratio 2.4 ± 3.3 2.2 ± 2.6 3.2 ± 4.5 1.1 ± 0.8 Not significant
SD: standard deviation; UPr: Urine protein; UCr: Urine creatinine; UPC: urine protein/creatinine.
Table 3. Frequencies of urine protein/creatinine ratio categories in dogs with serological diagnosis of canine visceral leishmaniasis 
from Barra Mansa, RJ - Brazil according to clinical groups.
Variable Dogs Symptomatic Oligosymptomatic Asymptomatic
UPC ratio
< 0.2 8 (17.8) 4 (21.05) 3 (17.7) 1 (11.1)
0.2 - 0.5 10 (22.2) 4 (21.05) 4 (23.5) 2 (22.2)
> 0.5 27 (60.0) 11 (57.9) 10 (58.8) 6 (66.7)
Total 45 (100) 19 (100.0) 17 (100.0) 9 (100)
Stratification of UPC ratio in proteinuric dogs
> 0.5 to 1.0 5 (18.5) 1 (9.1) 4 (40.0) 0
> 1.0 to 2.0 8 (29.6) 3 (27.3) 0 5 (83.3)
> 2.0 14 (51.9) 7 (63.6) 6 (60.0) 1 (16.7)
Total 27 (100) 11 (100) 10 (100) 6 (100)
*UPC: urine protein/creatinine.
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DISCUSSION
In our study, we observed a high frequency of 
dogs with one or more symptoms of CVL (42.2% of 
symptomatic dogs and 37.8% of oligosymptomatic 
dogs) and a low frequency of asymptomatic dogs 
(20.0%) at the time of sampling. This result is consis-
tent with that of another study in an endemic area for 
CVL in Brazil where 71% of symptomatic dogs are 
detected [4].
Pale yellow was the most frequent color ob-
served in the physical examination of urine, followed 
by amber. Different authors have reported that pale-
yellow urine may be associated with decreased urine 
specific gravity, which may suggest inability in renal 
tubular resorption and progression of chronic kidney 
disease [5,21,29]. Another investigation regarding 
dogs with CVL showed amber color in 70% of urine 
samples. According to the authors, the concentration 
of urochrome depends on the urine specific gravity and 
the pathological state of the animal [15].
More than half of the animals evaluated 
(51.1%) presented some degree of turbidity in their 
urine samples, which was similar among the three clini-
cal groups. Cloudy urine may be associated with the 
presence of epithelial cells, red blood cells, leukocytes, 
bacteria, and suspended mucus [21]. Besides, the pres-
ence of phosphate crystals that precipitate in alkaline 
urine is another common cause for the appearance 
of cloudy urine [29]. Since all the above-mentioned 
components were found in samples from animals with 
CVL, a high occurrence of cloudy urine was expected 
in the present study.
The total concentration of solutes determines 
the urine specific gravity, which remained predomi-
nantly within the normal range in our study. In 6.7% 
of dogs’ samples, the urine specific gravity was con-
sidered low, and dogs that presented this abnormality 
were symptomatic and oligosymptomatic. This finding 
was consistent with the occurrence of pale-yellow color 
in these groups and may suggest the inability of the 
kidneys to concentrate urine, a feature that has been 
reported by other authors, even in dogs with CVL 
[15,21,29].
The urine pH values remained within the ex-
pected range for most animals, and alkaline urine was 
the most frequent change observed in this study (26.7% 
of dogs). Variations in urinary pH are mainly related to 
the composition of the animals’ diet. However, patients 
with renal tubular acidosis (RTA) also have an inability 
to acidify their urine, keeping its pH in the alkaline 
range [21]. The RTA can occur secondary to other dis-
eases, being a transient or a permanent condition; and, 
despite the abundance of RTA reports in humans, only 
a few studies of such disorder in veterinary patients 
have been published [26].
Small amounts of bilirubin are occasionally 
present in dog urine, and this event is considered non-
pathological [19]. In our study, bilirubin values greater 
than 1+ were found both in symptomatic and asymp-
tomatic dogs. The progression of CVL may trigger ac-
tivation of Kupffer cells, in addition to an inflammatory 
reaction (capsular or portal) and intralobular formation 
of granulomas, causing liver damage [24], which may 
justify increased bilirubin in this work.
Glycosuria was identified in 6.7% of dogs 
with CVL. Blood glucose is known to be filtered by 
the glomeruli and reabsorbed by the proximal tubules. 
Thus, glycosuria may be present when the glomerular 
filtration rate exceeds resorption capacity (due to hy-
perglycemia); or when tubular resorption is deficient 
[21,29]. Although the occurrence of hyperglycemic 
disorders (such as diabetes mellitus or Cushing’s syn-
drome) has not been investigated in the present study, 
we cannot overlook the fact that L. infantum infection 
causes glomerular and tubular damage [8], justifying 
the presence of glucose in the urine samples. 
The dipstick test can detect peroxidase activity 
in erythrocytes, characterizing the existence of blood 
in the urine sample. However, both hemoglobin and 
myoglobin catalyze this reaction, which can be dis-
tinguished by the observation of erythrocytes in the 
microscopic examination of the urine sediment [29]. 
In our study, 46.7% of dogs had occult blood in the 
urine, 40.0% of dogs had red blood cells in the urine 
sediment, and 17.8% of dogs had hematuria. The cause 
of hematuria can be in the kidneys (renal hematuria; 
glomerular or non-glomerular) or in the low urinary 
tract. Renal hematuria is distinguished from other 
etiologies by the frequent presence of proteinuria and 
erythrocyte casts [1,29]. Researchers believe that tubu-
lar and glomerular lesions that occur in CVL [20,25,36] 
may have been the cause of occult blood and hematuria 
in the animals of the present study.
Although the presence of leukocytes in the uri-
nary sediment was frequent, only 8.9% of dogs had high 
counts in their samples, characterizing pyuria. Eryth-
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rocytes and leukocytes have been commonly found in 
urinalysis of humans and dogs with visceral leishmani-
asis [9,10,27]. Pyuria may contribute to urine turbidity, 
as well as being a strong indicator of pyelonephritis, 
glomerulonephritis and renal inflammatory processes, 
disorders identified in dogs with CVL [20,25,36].
The presence of small amounts of epithelial 
cells in the urine sediment may be considered normal 
[19,21,29]. However, the occurrence of these cells 
in moderate and excessive quantities, along with the 
presence of both renal pelvis and renal tubular cells 
requires attention, as it may be directly associated with 
marked renal damage [29].
The existence of granular and hyaline casts in 
the present study was expected and is in agreement with 
the results of other studies of dogs with CVL [2,12,25]. 
Casts are formed by mucoproteins, which precipitate 
and acquire a cylindrical shape as they pass through 
the renal tubules [11,23]. The occurrence of cylindruria 
suggests tubular injury in dogs with CVL, as proposed 
before [9,11,23,25]. Amorphous phosphate, struvite 
and calcium oxalate crystals were also observed in 
the present study. The presence of crystalluria in dogs 
infected with Leishmania spp. was also previously 
described; apparently, this finding is primarily related 
to changes in urinary pH and not to the presence of 
the parasite itself. In general, the amount of crystals 
is more significant than their shape, because crystals 
are a frequent finding in routine urine examinations 
[19,31,33]. It is noteworthy that struvite crystals may 
appear in cases of bacterial infection [29]. In addition 
to the increased urinary pH, our study also found bac-
teria in sediment samples, which may have favored the 
formation of struvite crystals along with the alkaline 
medium. Similar findings were previously described 
in dogs with CVL [15]. Unfortunately, more detailed 
techniques, including Gram staining and culture, were 
not performed on the sampled animals.
Proteinuria ≥ 1+ was identified in 80.0% of the 
samples by the urine dipstick test; this was the most 
frequently found abnormality in our study. Using the 
UPC ratio as a tool to assess proteinuria, the results were 
also high, as 60.0% of dogs with CVL were classified 
as proteinuric, and 22.2% of dogs were classified as 
borderline proteinuric. Interestingly, dipstick and UPC 
ratio demonstrated the occurrence of proteinuria even 
in asymptomatic animals. Proteinuria in dogs with CVL 
has also been reported in previous studies [12,16]. Renal 
disease may be the sole clinical manifestation of CVL; 
it can progress from slight proteinuria to the end-stage 
renal disease, resulting in chronic renal failure, which is 
the main cause of death due to CVL [30]. Stratification 
of the UPC ratio revealed that values higher than 2.0 
were significantly more frequent, particularly among 
symptomatic dogs. According to the literature, this result 
(UPC ratio > 2.0) is a strong indication of glomerular 
disease [14]. Therefore, our findings are as expected and 
reinforce that the progression of renal disease follows 
the clinical progression of CVL.
Proteinuria may be caused by modification of 
glomerular vascular permeability, immune complex 
deposition, vascular inflammation, intraglomerular 
hypertension, and tubulointerstitial dysfunction [14]. 
In dogs with visceral leishmaniasis, immune complex 
deposition is a frequent abnormality [2,3,10,34,35] 
and, in addition to tubular disease, justifies the results 
of the present study.
The increase in serum urea and creatinine lev-
els were observed only in 6.7% of the dogs sampled, 
which was expected, as these markers can only detect 
renal disease late, requiring the loss of approximately 
66% of nephrons [11]. On the other hand, azotemia is 
an uncommon finding in CVL-infected dogs, even in 
those with a high prevalence of kidney lesions [30]. 
The occurrence of proteinuric and non-azotemic CVL-
infected dogs has also been reported before [7].
CONCLUSION
In the present study, urinalysis was a useful tool 
for identifying renal abnormalities in dogs with CVL, 
although significant differences were not important 
between the clinical groups of the disease, reinforcing 
the fact that renal injury arises even before clinical 
signs become apparent. Variation in color, turbidity, 
glycosuria, increased cellularity, and presence of eryth-
rocytes and leukocytes were relevant elements detected 
in the animals infected by Leishmania infantum in our 
study. The high occurrence of occult blood, proteins, 
and casts, together with hematuria, confirmed the 
presence of tubular or glomerular lesions, or both, in 
CVL. The high frequency of symptomatic dogs with 
UPC ratio > 2.0 indicates that the progression of renal 
disease follows the clinical progression of CVL. The 
sole usage of serum markers (urea and creatinine) may 
underestimate the presence of kidney disease in dogs 
with CVL.
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